Targeting molecular pathway that causes pulmonary arterial hypertension
Published Date: 5/6/2022
Source: sciencedaily.com
Researchers describe the underlying signaling pathway that results in pulmonary arterial hypertension and a novel monoclonal antibody therapy that blocks the abnormal blood vessel formation characterizing the disease.
